| Literature DB >> 30721024 |
Minhee Lee1, Jinshi Zhao2, Seung-Hwa Kwak1, Jae Cho2, Myungju Lee3, Robert A Gillespie2, Do-Yeon Kwon1, Hyunji Lee1, Hyun-Ju Park4, Qinglin Wu2, Pei Zhou2, Jiyong Hong1.
Abstract
The UDP-2,3-diacylglucosamine pyrophosphatase LpxH in the Raetz pathway of lipid A biosynthesis is an essential enzyme in the vast majority of Gram-negative pathogens and an excellent novel antibiotic target. The 32P-radioautographic thin-layer chromatography assay has been widely used for analysis of LpxH activity, but it is inconvenient for evaluation of a large number of LpxH inhibitors over an extended time period. Here, we report a coupled, nonradioactive LpxH assay that utilizes the recently discovered Aquifex aeolicus lipid A 1-phosphatase LpxE for quantitative removal of the 1-phosphate from lipid X, the product of the LpxH catalysis; the released inorganic phosphate is subsequently quantified by the colorimetric malachite green assay, allowing the monitoring of the LpxH catalysis. Using such a coupled enzymatic assay, we report the biochemical characterization of a series of sulfonyl piperazine LpxH inhibitors. Our analysis establishes a preliminary structure-activity relationship for this class of compounds and reveals a pharmacophore of two aromatic rings, two hydrophobic groups, and one hydrogen-bond acceptor. We expect that our findings will facilitate the development of more effective LpxH inhibitors as potential antibacterial agents.Entities:
Keywords: Gram-negative bacteria; LpxE; LpxH; enzyme-coupled assay; lipid A; novel antibiotics
Mesh:
Substances:
Year: 2019 PMID: 30721024 PMCID: PMC6730544 DOI: 10.1021/acsinfecdis.8b00364
Source DB: PubMed Journal: ACS Infect Dis ISSN: 2373-8227 Impact factor: 5.084